Protein, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease
Protein Intake, Nutrition and Cardiovascular Disease in Stage 5 Chronic Kidney Disease (CKD)
2 other identifiers
observational
145
1 country
2
Brief Summary
National Kidney Foundation guidelines recommend a dietary protein intake of 1.2 grams per kilogram per day (g/kg/d) in hemodialysis patients. However, it is unclear whether consumption of high amounts of protein in dialysis patients has beneficial or harmful nutritional and cardiovascular effects in this population. High protein intake might improve nutritional status, but it has been argued that the state of low muscle mass, small body size and low serum protein levels is not the result of decreased dietary intake, rather a result of hypercatabolism induced by metabolic acidosis, inflammation and oxidative stress. The specific aims of this study are to examine in a prospective cohort of hemodialysis patients the longitudinal associations of absolute total protein intake or dietary protein intake with muscle mass and arterial stiffness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2007
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2007
CompletedFirst Submitted
Initial submission to the registry
November 29, 2007
CompletedFirst Posted
Study publicly available on registry
December 3, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedAugust 11, 2016
August 1, 2016
8.1 years
November 29, 2007
August 9, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation of muscle mass with protein intake
Mid-thigh muscle mass measured by magnetic resonance imaging
Baseline and 18 months
Secondary Outcomes (1)
Correlation of arterial stiffness with protein intake
Baseline and 18 months
Study Arms (1)
Observation (all participants)
Stage 5 Chronic Kidney Disease and hemodialysis patients
Eligibility Criteria
University of Utah Dialysis Program patients, and Vanderbilt University dialysis patients.
You may qualify if:
- Adult stage 5 chronic kidney disease patients, on dialysis for at least 3 months.
- Urine output \> 200 mL/day
You may not qualify if:
- Patients with persistent volume overload (substantial pedal edema) despite attempts at achieving dry weight
- Patients with inability to walk or who use a wheel-chair with reduced mid-thigh muscle mass
- Persons with pacemakers, cochlear implants, or other prohibitive conditions for magnetic resonance imaging
- Atrial fibrillation
- Patients who are unlikely or unable (in the opinion of the nephrologists, nurses or dieticians taking care of the patient) to comply with research protocol
- Patients with symptomatic heart failure, current active malignancy (excluding squamous and basal cell skin cancers), active AIDS, chronic lung disease requiring supplemental oxygen therapy and cirrhosis
- Patients enrolled in interventional trials
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator
- Vanderbilt Universitycollaborator
Study Sites (2)
Vanderbilt University Medical Centet
Nashville, Tennessee, 37232-2372, United States
University of Utah
Salt Lake City, Utah, 84112, United States
Biospecimen
30 ml of blood drawn four times (months 1, 6, 12 and 18) for plasma/serum/DNA samples. Urine Collection: If patients are making more than ½ cup (200 ml) of urine a day.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Srinivasan Beddhu, M.D
University of Utah
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
November 29, 2007
First Posted
December 3, 2007
Study Start
September 1, 2007
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
August 11, 2016
Record last verified: 2016-08